Characteristics of Human Leukocyte Antigen Class II Genes in Japanese Patients with Type 1 Diabetes and Autoimmune Thyroid Disease.
Humans
Diabetes Mellitus, Type 1
/ genetics
Female
Male
Adult
Alleles
Genetic Predisposition to Disease
HLA-DRB1 Chains
/ genetics
Japan
Asian People
/ genetics
Thyroiditis, Autoimmune
/ genetics
Middle Aged
Gene Frequency
/ genetics
Genes, MHC Class II
/ genetics
Histocompatibility Antigens Class II
/ genetics
Young Adult
Adolescent
East Asian People
autoimmune thyroid disease, Graves’ disease, human leukocyte antigen class II genes, Japanese patients, Type 1 diabetes
Journal
The Tohoku journal of experimental medicine
ISSN: 1349-3329
Titre abrégé: Tohoku J Exp Med
Pays: Japan
ID NLM: 0417355
Informations de publication
Date de publication:
09 Jul 2024
09 Jul 2024
Historique:
medline:
11
7
2024
pubmed:
2
5
2024
entrez:
1
5
2024
Statut:
ppublish
Résumé
Genetic factors, particularly human leukocyte antigen (HLA) class II genes, are known to significantly influence the onset of type 1 diabetes (T1D). Additionally, patients with T1D often develop autoimmune thyroid diseases (AITD). Despite this association, comprehensive research on individuals with both AITD and T1D in Japan, especially regarding the influence of specific HLA alleles, remains insufficient. In this retrospective study, we analyzed 44 inpatients diagnosed with T1D. These patients were predominantly female, with an average onset age of 35 years, poor blood sugar control, and approximately 43.2% had concurrent AITD. We observed significant associations of HLA-DRB1*04:05, HLA-DRB1*09:01 and HLA-DRB1*15:02 alleles with T1D regardless of AITD presence, which had been previously established for T1D in Japanese. In this context, comparing Japanese patients with AITD alone, we noted AITD comorbidity with T1D results in alterations in the frequencies of HLA-DRB1*09:01, HLA-DRB1*04:03, and HLA-DRB1*15:02. Furthermore, HLA-DRB1*04:05, HLA-DRB1*09:01, HLA-DRB1*13:02, and HLA-DRB1*15:01 alleles may be alleles whose susceptibility varies for both conditions. These findings underscore the importance of understanding the relationship between T1D, AITD, and HLA genetics, which may inform personalized treatment strategies and facilitate the development of targeted therapies. Future research endeavors should aim to elucidate underlying mechanisms and validate these findings in larger cohorts.
Identifiants
pubmed: 38692862
doi: 10.1620/tjem.2024.J027
doi:
Substances chimiques
HLA-DRB1 Chains
0
Histocompatibility Antigens Class II
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM